We are live on
!
Find out more
ENZY
Enzymotec Ltd
ENZY
ENZY
Delisted
ENZY was delisted on the 10th of January, 2018.
37 hedge funds and large institutions have $97.1M invested in Enzymotec Ltd in 2017 Q4 according to their latest regulatory filings, with 25 funds opening new positions, 3 increasing their positions, 4 reducing their positions, and 8 closing their positions.
New
Increased
Maintained
Reduced
Closed
213% more first-time investments, than exits
New positions opened: 25 | Existing positions closed: 8
138% more capital invested
Capital invested by funds: $40.7M → $97.1M (+$56.4M)
85% more funds holding
Funds holding: 20 → 37 (+17)
25% less repeat investments, than reductions
Existing positions increased: 3 | Existing positions reduced: 4
Holders
37
Holders Change
+17
Holders Change %
+85%
% of All Funds
0.84%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
25
Increased
3
Reduced
4
Closed
8
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–
Top Buyers
| 1 |
GF
Gabelli Funds
Rye,
New York
|
+$6.69M |
| 2 |
GH
GAM Holding
Zurich,
Switzerland
|
+$6.15M |
| 3 |
WIC
Water Island Capital
New York
|
+$4.64M |
| 4 |
WRBC
W.R. Berkley Corp
Greenwich,
Connecticut
|
+$3.2M |
| 5 |
Renaissance Technologies
New York
|
+$3.07M |
Top Sellers
| 1 |
TM
Tiger Management
New York
|
-$7.76M |
| 2 |
T. Rowe Price Associates
Baltimore,
Maryland
|
-$458K |
| 3 |
Fidelity Investments
Boston,
Massachusetts
|
-$331K |
| 4 |
Acadian Asset Management
Boston,
Massachusetts
|
-$207K |
| 5 |
CS
Credit Suisse
Zurich,
Switzerland
|
-$184K |
